Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0130 (-34.21%)
At close: Jan 23, 2026
BZYR Market Cap
BZYR has a market cap or net worth of $5 million as of January 23, 2026. Its market cap has decreased by -34.48% in one year.
Market Cap
5.00M
Enterprise Value
4.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 5.00M, a decrease of -69.56%. That is a compound annual growth rate of -4.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.29M | 30.89% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 7.07M |
| Curative Biotechnology | 6.54M |
| Brainstorm Cell Therapeutics | 6.47M |
| BetterLife Pharma | 6.08M |
| Nymox Pharmaceutical | 5.94M |
| Clearside Biomedical | 5.71M |
| GPL Holdings | 5.33M |
| Mosaic ImmunoEngineering | 3.61M |